You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
龍津藥業(002750.SZ):擬向龍津梵天增資4800萬元
格隆匯 09-01 19:30

格隆匯 9 月 1日丨龍津藥業(002750.SZ)公佈,因業務發展需要,公司全資子公司雲南龍津梵天生物科技有限責任公司(“龍津梵天”)擬新增註冊資本4800萬元。

增資完成後,龍津梵天註冊資本將增加至7350萬元,新增註冊資本將用於1)龍津梵天向江蘇龍津康佑生物醫藥有限責任公司(“龍津康佑”)等子公司繳付出資款、滿足日常運營所需資金等用途;2)龍津梵天直接或間接對外投資新設立控股子公司昆明龍津藥業銷售有限公司(暫定名,“銷售公司”)。

工業和商業協同發展是中國醫藥行業未來發展趨勢之一,公司將通過銷售公司預先培育產品渠道市場、專業人員綜合能力,以銷售公司作為預先培育產品渠道市場、專業人員綜合能力的平台,協助新產品實現銷售,可以縮短新上市產品上市的週期並快速實現多銷售渠道和市場覆蓋率,能補充目前相對單一的產品渠道、客户資源和疾病領域,為各類服務產品和市場領域客户提供一個專業性銷售、推廣平台,進一步增強公司可持續發展能力,對於提升公司核心競爭力也將產生積極影響,符合公司和股東的長遠利益。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account